Skip to main content
. 2019 Apr 8;21(7):890–900. doi: 10.1093/neuonc/noz060

Fig. 6.

Fig. 6

Combination of suicide gene therapy with erlotinib does not improve therapeutic efficacy. (A) Kaplan–Meier survival analysis does not show a significant difference between double treatment and single treatment arms. (B) Immunohistochemical stainings with antibodies against pEGFR 1068. Scale bar: 50 μm. (C) Quantification showing percentage of pEGFR 1068+ area fraction. (D, E) Immunohistochemical stainings with antibodies against EGFR and quantification of EGFR+ area fraction.